Cara Therapeutics Inc to Discuss the US License Agreement for I.V. Korsuva with Vifor Pharma PLC Call Transcript
Good morning and welcome to Cara Therapeutics/Vifor Pharma License Conference Call. (Operator Instructions)
Please be advised that this call is being recorded by Cara's request.
I would now like to turn the call over to the Cara team. Please proceed.
Good morning. This is Jack Hildick-Smith with Stern Investor Relations and welcome to Cara Therapeutics/Vifor Pharma License Update Conference Call.
The news release describing the details of this license agreement became available at 1 a.m. today and can be found on our website at www.caratherapeutics.com, with further details available in a current report on Form 8-K filed with the U.S. Securities and Exchange Commission this morning. A PowerPoint slide deck describing the details of the Vifor license is posted on the Investors section of the website, and you may also listen to a live webcast and replay of today's call on the same
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |